| Year |
Citation |
Score |
| 2020 |
Panda A, Yadav A, Yeerna H, Singh A, Biehl M, Lux M, Schulz A, Klecha T, Doniach S, Khiabanian H, Ganesan S, Tamayo P, Bhanot G. Tissue- and development-stage-specific mRNA and heterogeneous CNV signatures of human ribosomal proteins in normal and cancer samples. Nucleic Acids Research. PMID 32525984 DOI: 10.1093/Nar/Gkaa485 |
0.331 |
|
| 2019 |
Santana LM, Ganesan S, Bhanot G. A Quasi Birth-and-Death Model For Tumor Recurrence. Journal of Theoretical Biology. PMID 31374283 DOI: 10.1016/J.Jtbi.2019.07.017 |
0.305 |
|
| 2019 |
Singh A, Bhanot G, Khiabanian H. TuBA: Tunable biclustering algorithm reveals clinically relevant tumor transcriptional profiles in breast cancer. Gigascience. 8. PMID 31216036 DOI: 10.1093/Gigascience/Giz064 |
0.33 |
|
| 2019 |
Panda A, Stein MN, Riedlinger G, Bhanot G, Ganesan S. Role for immune checkpoint blockade in BRCA2-mutant prostate cancer. Journal of Clinical Oncology. 37: 59-59. DOI: 10.1200/Jco.2019.37.8_Suppl.59 |
0.325 |
|
| 2019 |
Ganesan S, Panda A, Bhanot G. Abstract B076: Pan-cancer analysis to identify which cancers may benefit most from LAG-3 blockade Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-B076 |
0.327 |
|
| 2018 |
Smith CC, Beckermann KE, Bortone DS, de Cubas AA, Bixby LM, Lee SJ, Panda A, Ganesan S, Bhanot G, Wallen EM, Milowsky MI, Kim WY, Rathmell WK, Swanstrom R, Parker JS, et al. Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma. The Journal of Clinical Investigation. PMID 30137025 DOI: 10.1172/Jci121476 |
0.32 |
|
| 2018 |
Panda A, de Cubas AA, Stein M, Riedlinger G, Kra J, Mayer T, Smith CC, Vincent BG, Serody JS, Beckermann KE, Ganesan S, Bhanot G, Rathmell WK. Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma. Jci Insight. 3. PMID 30135306 DOI: 10.1172/Jci.Insight.121522 |
0.334 |
|
| 2018 |
Panda A, De Cubas A, Beckermann K, Riedlinger G, Stein MN, Mayer TM, Mehnert JM, Rathmell K, Bhanot G, Ganesan S. Expression of endogenous retroviruses and response to immune checkpoint therapy in renal cell cancer. Journal of Clinical Oncology. 36: 104-104. DOI: 10.1200/Jco.2018.36.5_Suppl.104 |
0.328 |
|
| 2017 |
Bjørklund SS, Panda A, Kumar S, Seiler M, Robinson D, Gheeya J, Yao M, Alnæs GIG, Toppmeyer D, Riis M, Naume B, Børresen-Dale AL, Kristensen VN, Ganesan S, Bhanot G. Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma. Scientific Reports. 7: 5568. PMID 28717182 DOI: 10.1038/S41598-017-05537-0 |
0.347 |
|
| 2017 |
Ganesan S, Bhanot G, Mehnert JM, Silk AW, Ross JS, Pavlick D, Ali SM, Markowski P, Kaufman HL, Sullivan RJ, Lovly CM, Sosman JA, Johnson DB, Betigeri A, Subramanian K, et al. Mutation burden as a biomarker of response to immune checkpoint therapy in nine solid cancers. Journal of Clinical Oncology. 35: 35-35. DOI: 10.1200/Jco.2017.35.7_Suppl.35 |
0.338 |
|
| 2016 |
Mehnert JM, Panda A, Zhong H, Hirshfield K, Damare S, Lane K, Sokol L, Stein MN, Rodriguez-Rodriquez L, Kaufman HL, Ali S, Ross JS, Pavlick DC, Bhanot G, White EP, et al. Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer. The Journal of Clinical Investigation. PMID 27159395 DOI: 10.1172/Jci84940 |
0.314 |
|
| 2016 |
Panda A, Betigeri A, Subramanian K, Hirshfield K, Rodriguez L, Ganesan S, Bhanot G. Abstract 1424: Predicting response to immune checkpoint therapy using an mutation burden threshold Cancer Research. 76: 1424-1424. DOI: 10.1158/1538-7445.Am2016-1424 |
0.302 |
|
| 2015 |
Bjørklund SS, Kristensen VN, Seiler M, Kumar S, Alnæs GI, Ming Y, Kerrigan J, Naume B, Sachidanandam R, Bhanot G, Børresen-Dale AL, Ganesan S. Expression of an estrogen-regulated variant transcript of the peroxisomal branched chain fatty acid oxidase ACOX2 in breast carcinomas. Bmc Cancer. 15: 524. PMID 26183823 DOI: 10.1186/S12885-015-1510-8 |
0.38 |
|
| 2015 |
Pimenta EM, De S, Weiss R, Feng D, Hall K, Kilic S, Bhanot G, Ganesan S, Ran S, Barnes BJ. IRF5 is a novel regulator of CXCL13 expression in breast cancer that regulates CXCR5(+) B- and T-cell trafficking to tumor-conditioned media. Immunology and Cell Biology. 93: 486-99. PMID 25533286 DOI: 10.1038/Icb.2014.110 |
0.317 |
|
| 2015 |
Hormoz S, Bhanot G, Biehl M, Bilal E, Meyer P, Norel R, Rhrissorrakrai K, Dayarian A. Inter-species inference of gene set enrichment in lung epithelial cells from proteomic and large transcriptomic datasets. Bioinformatics (Oxford, England). 31: 492-500. PMID 25152231 DOI: 10.1093/Bioinformatics/Btu569 |
0.641 |
|
| 2015 |
Dayarian A, Romero R, Wang Z, Biehl M, Bilal E, Hormoz S, Meyer P, Norel R, Rhrissorrakrai K, Bhanot G, Luo F, Tarca AL. Predicting protein phosphorylation from gene expression: top methods from the IMPROVER Species Translation Challenge. Bioinformatics (Oxford, England). 31: 462-70. PMID 25061067 DOI: 10.1093/Bioinformatics/Btu490 |
0.664 |
|
| 2015 |
Biehl M, Sadowski P, Bhanot G, Bilal E, Dayarian A, Meyer P, Norel R, Rhrissorrakrai K, Zeller MD, Hormoz S. Inter-species prediction of protein phosphorylation in the sbv IMPROVER species translation challenge. Bioinformatics (Oxford, England). 31: 453-61. PMID 24994890 DOI: 10.1093/Bioinformatics/Btu407 |
0.634 |
|
| 2015 |
Ganesan S, Alexe G, Hirshfield KM, Yao M, Bhanot G, Deborah T. Abstract P5-04-10: Characterization of the immune infiltrate in HER2+ breast cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P5-04-10 |
0.351 |
|
| 2015 |
Hirshfield KM, Sanders R, Feld HK, Barnard N, Liang L, Zhong H, Bhanot G, Sahota AS, Brooks A, Rodriguez-Rodriguez L, Ganesan S. Abstract 4798: Genomic alterations in ERBB2 define a subset of pleomorphic invasive lobular breast cancer Cancer Research. 75: 4798-4798. DOI: 10.1158/1538-7445.Am2015-4798 |
0.335 |
|
| 2015 |
Kumar S, Seiler M, Bjørklund S, Børresen-Dale A, Kristensen V, Bhanot G, Ganesan S. Abstract 150: Long non-coding RNA are differentially expressed in breast cancer clinical subtypes Cancer Research. 75: 150-150. DOI: 10.1158/1538-7445.Am2015-150 |
0.337 |
|
| 2015 |
Bjørklund S, Kristensen VN, Seiler M, Alnaes GIG, Ming Y, Kerrigan J, Naume B, Sachidanandam R, Bhanot G, Børresen-Dale A, Ganesan S. Abstract 1083: Expression of an estrogen-regulated variant transcript of the peroxisomal branched chain fatty acid oxidase, ACOX2, in breast cancer Cancer Research. 75: 1083-1083. DOI: 10.1158/1538-7445.Am2015-1083 |
0.315 |
|
| 2015 |
Mehnert JM, Panda A, Zhong H, Hirshfield KM, Damare S, Stiles K, Sokol L, Stein MN, Rodriguez-Rodriguez L, Kaufman HL, Ali S, Ross J, Pavlick DC, Bhanot G, White EP, et al. Abstract PR05: Exceptional Response to PD-1 antibody treatment in a POLE-mutant endometrial cancer Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-Pr05 |
0.329 |
|
| 2014 |
Davis CF, Ricketts CJ, Wang M, Yang L, Cherniack AD, Shen H, Buhay C, Kang H, Kim SC, Fahey CC, Hacker KE, Bhanot G, Gordenin DA, Chu A, Gunaratne PH, et al. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell. 26: 319-30. PMID 25155756 DOI: 10.1016/J.Ccr.2014.07.014 |
0.312 |
|
| 2014 |
Wagh K, Bhatia A, Greenbaum BD, Bhanot G. Bird to human transmission biases and vaccine escape mutants in H5N1 infections. Plos One. 9: e100754. PMID 24988306 DOI: 10.1371/Journal.Pone.0100754 |
0.697 |
|
| 2014 |
Lozy F, Cai-McRae X, Teplova I, Price S, Reddy A, Bhanot G, Ganesan S, Vazquez A, Karantza V. ERBB2 overexpression suppresses stress-induced autophagy and renders ERBB2-induced mammary tumorigenesis independent of monoallelic Becn1 loss. Autophagy. 10: 662-76. PMID 24492513 DOI: 10.4161/Auto.27867 |
0.377 |
|
| 2014 |
Bhatia A, Yadav A, Zhu C, Gagneur J, Radhakrishnan A, Steinmetz LM, Bhanot G, Sinha H. Yeast growth plasticity is regulated by environment-specific multi-QTL interactions. G3 (Bethesda, Md.). 4: 769-77. PMID 24474169 DOI: 10.1534/G3.113.009142 |
0.554 |
|
| 2013 |
Tomar P, Bhatia A, Ramdas S, Diao L, Bhanot G, Sinha H. Sporulation genes associated with sporulation efficiency in natural isolates of yeast. Plos One. 8: e69765. PMID 23874994 DOI: 10.1371/Journal.Pone.0069765 |
0.587 |
|
| 2012 |
Joshi H, Bhanot G, Børresen-Dale AL, Kristensen V. Potential tumorigenic programs associated with TP53 mutation status reveal role of VEGF pathway. British Journal of Cancer. 107: 1722-8. PMID 23079576 DOI: 10.1038/Bjc.2012.461 |
0.32 |
|
| 2012 |
Wagh K, Bhatia A, Alexe G, Reddy A, Ravikumar V, Seiler M, Boemo M, Yao M, Cronk L, Naqvi A, Ganesan S, Levine AJ, Bhanot G. Lactase persistence and lipid pathway selection in the Maasai. Plos One. 7: e44751. PMID 23028602 DOI: 10.1371/Journal.Pone.0044751 |
0.717 |
|
| 2012 |
Toth ML, Melentijevic I, Shah L, Bhatia A, Lu K, Talwar A, Naji H, Ibanez-Ventoso C, Ghose P, Jevince A, Xue J, Herndon LA, Bhanot G, Rongo C, Hall DH, et al. Neurite sprouting and synapse deterioration in the aging Caenorhabditis elegans nervous system. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 8778-90. PMID 22745480 DOI: 10.1523/Jneurosci.1494-11.2012 |
0.548 |
|
| 2012 |
Bilal E, Vassallo K, Toppmeyer D, Barnard N, Rye IH, Almendro V, Russnes H, Børresen-Dale AL, Levine AJ, Bhanot G, Ganesan S. Amplified loci on chromosomes 8 and 17 predict early relapse in ER-positive breast cancers. Plos One. 7: e38575. PMID 22719901 DOI: 10.1371/Journal.Pone.0038575 |
0.689 |
|
| 2012 |
Powell AA, Talasaz AH, Zhang H, Coram MA, Reddy A, Deng G, Telli ML, Advani RH, Carlson RW, Mollick JA, Sheth S, Kurian AW, Ford JM, Stockdale FE, Quake SR, ... ... Bhanot G, et al. Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines. Plos One. 7: e33788. PMID 22586443 DOI: 10.1371/Journal.Pone.0033788 |
0.372 |
|
| 2012 |
Vermeer PD, Bell M, Lee K, Vermeer DW, Wieking BG, Bilal E, Bhanot G, Drapkin RI, Ganesan S, Klingelhutz AJ, Hendriks WJ, Lee JH. ErbB2, EphrinB1, Src kinase and PTPN13 signaling complex regulates MAP kinase signaling in human cancers. Plos One. 7: e30447. PMID 22279592 DOI: 10.1371/Journal.Pone.0030447 |
0.685 |
|
| 2012 |
Ganesan S, Bhanot G, Boemo M, Lee J. Abstract P1-05-19: Modeling Cancer Recurrence and the Therapeutic Effect of Adjuvant Systemic Therapy Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P1-05-19 |
0.343 |
|
| 2011 |
Lozy FJ, Reddy A, Miles G, Bhanot G, Ganesan S, Karantza V. Abstract 3777: Autophagy and HER2 interaction in mammary tumorigenesis Cancer Research. 71: 3777-3777. DOI: 10.1158/1538-7445.Am2011-3777 |
0.386 |
|
| 2010 |
Bilal E, Alexe G, Yao M, Cong L, Kulkarni A, Ginjala V, Toppmeyer D, Ganesan S, Bhanot G. Identification of the YES1 Kinase as a Therapeutic Target in Basal-Like Breast Cancers. Genes & Cancer. 1: 1063-73. PMID 21779430 DOI: 10.1177/1947601910395583 |
0.702 |
|
| 2010 |
Brannon AR, Reddy A, Seiler M, Arreola A, Moore DT, Pruthi RS, Wallen EM, Nielsen ME, Liu H, Nathanson KL, Ljungberg B, Zhao H, Brooks JD, Ganesan S, Bhanot G, et al. Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns. Genes & Cancer. 1: 152-163. PMID 20871783 DOI: 10.1177/1947601909359929 |
0.316 |
|
| 2010 |
Irgon J, Huang CC, Zhang Y, Talantov D, Bhanot G, Szalma S. Robust multi-tissue gene panel for cancer detection. Bmc Cancer. 10: 319. PMID 20569444 DOI: 10.1186/1471-2407-10-319 |
0.329 |
|
| 2010 |
Fatakdawala H, Xu J, Basavanhally A, Bhanot G, Ganesan S, Feldman M, Tomaszewski JE, Madabhushi A. Expectation-maximization-driven geodesic active contour with overlap resolution (EMaGACOR): application to lymphocyte segmentation on breast cancer histopathology. Ieee Transactions On Bio-Medical Engineering. 57: 1676-89. PMID 20172780 DOI: 10.1109/Tbme.2010.2041232 |
0.302 |
|
| 2010 |
Juan D, Alexe G, Antes T, Liu H, Madabhushi A, Delisi C, Ganesan S, Bhanot G, Liou LS. Identification of a microRNA panel for clear-cell kidney cancer. Urology. 75: 835-41. PMID 20035975 DOI: 10.1016/J.Urology.2009.10.033 |
0.309 |
|
| 2010 |
Norton KA, Wininger M, Bhanot G, Ganesan S, Barnard N, Shinbrot T. A 2D mechanistic model of breast ductal carcinoma in situ (DCIS) morphology and progression. Journal of Theoretical Biology. 263: 393-406. PMID 20006623 DOI: 10.1016/J.Jtbi.2009.11.024 |
0.32 |
|
| 2010 |
Brannon AR, Reddy A, Seiler M, Arreola A, Chen S, Moore DT, Pruthi RS, Wallen EM, Nielsen ME, Liu H, Ljungberg B, Zhao H, Brooks JD, Ganesan S, Bhanot G, et al. Abstract 1996: Molecular stratification of clear cell renal cell carcinoma by consensus clustering reveals distinct subtypes and survival patterns Cancer Research. 70: 1996-1996. DOI: 10.1158/1538-7445.Am10-1996 |
0.344 |
|
| 2009 |
Lexe G, Monaco J, Doyle S, Basavanhally A, Reddy A, Seiler M, Ganesan S, Bhanot G, Madabhushi A. Towards improved cancer diagnosis and prognosis using analysis of gene expression data and computer aided imaging. Experimental Biology and Medicine (Maywood, N.J.). 234: 860-79. PMID 19491367 DOI: 10.3181/0902-Mr-89 |
0.349 |
|
| 2009 |
Ganesan S, Madabhushi A, Basavanhally A, Xu J, Bhanot G, Barnard N, Toppmeyer D. Computerized Histologic Image-Based Risk Score (IbRiS) Classifier for ER+ Breast Cancer. Cancer Research. 69: 3046-3046. DOI: 10.1158/0008-5472.Sabcs-09-3046 |
0.355 |
|
| 2009 |
Tadigotla V, Alexe G, Sethi N, Bilal E, Huang C, Monti S, Tamayo P, DeLisi C, Bhanot G, Ganesan S. NF-κB Activation in Breast Cancer Occurs Via Different Mechanisms in Triple Negative and HER2+ Tumors with Lymphocytic Infiltrate. Cancer Research. 69: 1164-1164. DOI: 10.1158/0008-5472.Sabcs-09-1164 |
0.681 |
|
| 2009 |
Aly A, Yang Q, Bilal E, Yao M, Bhanot G, Toppmeyer D, Haffty B, Ganesan S. Abnormalities of 53BP1 in Basal-Like Breast Cancer. Cancer Research. 69: 1122-1122. DOI: 10.1158/0008-5472.Sabcs-09-1122 |
0.7 |
|
| 2009 |
Reddy A, Ganesan S, Bhanot G. Abstract C37: Ensemble survival prediction for breast cancer using microarray data Cancer Research. 69. DOI: 10.1158/0008-5472.Fbcr09-C37 |
0.335 |
|
| 2009 |
Bilal E, Ganesan S, Bhanot G. Abstract C34: Amplifiedlocion chromosomes 8 and 17 predict Tamoxifen resistance in ER+ breast tumors Cancer Research. 69. DOI: 10.1158/0008-5472.Fbcr09-C34 |
0.695 |
|
| 2009 |
Bilal E, Rabadan R, Alexe G, Fuku N, Ueno H, Nishigaki Y, Fujita Y, Ito M, Arai Y, Hirose N, Ruckenstein A, Bhanot G, Tanaka M. 2. mtDNA Haplogroup D4a is a Marker for Extreme Longevity in Japan Mitochondrion. 9: 61. DOI: 10.1016/J.Mito.2008.12.004 |
0.639 |
|
| 2008 |
Bilal E, Rabadan R, Alexe G, Fuku N, Ueno H, Nishigaki Y, Fujita Y, Ito M, Arai Y, Hirose N, Ruckenstein A, Bhanot G, Tanaka M. Mitochondrial DNA haplogroup D4a is a marker for extreme longevity in Japan. Plos One. 3: e2421. PMID 18545700 DOI: 10.1371/Journal.Pone.0002421 |
0.664 |
|
| 2007 |
Alexe G, Dalgin GS, Scanfeld D, Tamayo P, Mesirov JP, Ganesan S, Delisi C, Bhanot G. Breast cancer stratification from analysis of micro-array data of micro-dissected specimens. Genome Informatics. International Conference On Genome Informatics. 18: 130-40. PMID 18546481 DOI: 10.11234/Gi1990.18.130 |
0.361 |
|
| 2007 |
Alexe G, Dalgin GS, Scanfeld D, Tamayo P, Mesirov JP, DeLisi C, Harris L, Barnard N, Martel M, Levine AJ, Ganesan S, Bhanot G. High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates. Cancer Research. 67: 10669-76. PMID 18006808 DOI: 10.1158/0008-5472.Can-07-0539 |
0.371 |
|
| 2007 |
Alexe G, Dalgin GS, Ganesan S, Delisi C, Bhanot G. Analysis of breast cancer progression using principal component analysis and clustering. Journal of Biosciences. 32: 1027-39. PMID 17914245 DOI: 10.1007/S12038-007-0102-4 |
0.339 |
|
| 2007 |
Alexe G, Fuku N, Bilal E, Ueno H, Nishigaki Y, Fujita Y, Ito M, Arai Y, Hirose N, Bhanot G, Tanaka M. Enrichment of longevity phenotype in mtDNA haplogroups D4b2b, D4a, and D5 in the Japanese population. Human Genetics. 121: 347-56. PMID 17308896 DOI: 10.1007/S00439-007-0330-6 |
0.653 |
|
| 2006 |
Bhanot G, Alexe G, Venkataraghavan B, Levine AJ. A robust meta-classification strategy for cancer detection from MS data. Proteomics. 6: 592-604. PMID 16342141 DOI: 10.1002/Pmic.200500192 |
0.304 |
|
| Show low-probability matches. |